axicabtagene ciloleucel
daiichi sankyo,gilead
['evolution,(-revolution)']
excited to be at #sitc22 in boston! i am thrilled to be speaking in the sat am (session 301) on resistance to checkpoint blockade therapy where i will share our latest work on caf evolution and function in the tme and impact on icb. should be an awesome session! 